LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers by Knuth A, Old LJ, Hoffman E, Gnjatic S, Jäger D, Biskamp M, Neumann A, Karbach J, Bender A, Jäger E

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. by Jäger, E, Nagata, Y, Gnjatic, S, Wada, H, Stockert, E, Karbach, J, Dunbar, P, Lee, S, Jungbluth, A, Jäger, D, Arand, M, Ritter, G, Cerundolo, V, Dupont, B, Chen, Y, Old, L, Knuth, A